Experts discuss how clinicians, healthcare leaders, and payers can prioritize incorporating cardiac rehabilitation as part of the standard of care for patients with heart failure.
A team of researchers propose that a population-based study of infective endocarditis in one county in Minnesota provides a unique opportunity to define temporal and seasonal variations in incidence over an extended period.
This registry-based cohort study aimed to assess both the frequency of prescription of concomitant aspirin (ASA) and DOAC therapy as well as its effect on clinical outcomes in patients with AF or VTE.
Although more research is needed, data suggest that the cardioprotective effect of direct oral anticoagulants may extend to patients with advanced CKD.
The patients, a 71-year-old male and a 62 year-old-male, both on long-term warfarin therapy, presented to the emergency department with symptoms of COVID-19.
The researchers’ goals include systematically reviewing the existing evidence of cardiovascular involvement in infectious diseases, including tropical infectious diseases.
The study authors analyzed the association of atrial fibrillation recurrence with heart failure, atrial fibrillation burden, and clinical outcomes in HF patients with AF.
Study authors evaluated whether using an observational study that includes Medicare claims data could detect the proarrhythmic risk of medications known to prolong the QT interval.
